FindMyRecallSubscribe
Class I: serious health riskOngoing

Endo Clonazepam Orally Disintegrating Tablets Recall

Clonazepam Orally Disintegrating Tablets, USP, 0

Endo USA, Inc. · Malvern, PA

Risk level
Class I
Reported by FDA
Jan 15, 2025
Recall ID
D-0180-2025
Check your lot numberHow we source this data

Summary

Endo recalled Clonazepam Orally Disintegrating Tablets starting Nov 18, 2024. The FDA classified it as Class I (serious health risk) and published enforcement report D-0180-2025 on Jan 15, 2025. Reason: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength. Status: Ongoing.

Why it was recalled

Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Product description

Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-307-02 (carton), NDC #: 49884-307-52 (blisters).

Lot numbers, UPCs & expiration codes

Lot #s: 550142801, 550142901, 550143001, 550143101, 550143201, 550143301, 550143401, 550147201, 550147401, Exp. 08/31/2026.

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0180-2025
Classification
Class I
Status
Ongoing
Recall initiated
Nov 18, 2024
FDA report date
Jan 15, 2025
Quantity
72,973 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Endo USA, Inc.

Original FDA data

Every field from FDA enforcement report D-0180-2025, exactly as published.

Show all FDA fields
City
Malvern
State
PA
Status
Ongoing
Country
United States
Event ID
95778
Address
1400 Atwater Dr
Code information
Lot #s: 550142801, 550142901, 550143001, 550143101, 550143201, 550143301, 550143401, 550147201, 550147401, Exp. 08/31/2026.
Postal code
19355-8701
Report date
Jan 15, 2025
Product type
Drugs
Recall number
D-0180-2025
Classification
Class I
Recalling firm
Endo USA, Inc.
Product quantity
72,973 cartons
Reason for recall
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cards containing 6 tablets each), Distributed by: PAR Pharmaceutical, Chestnut Ridge, NY 10977, NDC#: 49884-307-02 (carton), NDC #: 49884-307-52 (blisters).
Distribution pattern
Nationwide in the USA
Recall initiation date
Nov 18, 2024
Initial firm notification
Press Release
Center classification date
Jan 3, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0180-2025, published Jan 15, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls